☰
Virogentics has launched clinical trials in the Democratic Republic of Congo, focusing on the HIV/AIDS treatment supervised by Neuro Pharma Ltd.
Preparations for clinical studies targeting type 2 diabetes are underway, with promising preliminary findings suggesting significant potential for ITV-1's applications.